Myriad Genetics, Inc. Provides Financial Guidance for 2023 and 2024
Myriad Genetics introduces its 2024 revenue guidance of between $815 million and $835 million, or 9% - 11% growth over the mid-point of the 2023 revenue guidance range.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.2 USD | -0.39% |
|
+4.79% | +21.21% |
1st Jan change | Capi. | |
---|---|---|
+21.21% | 2.1B | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
-9.38% | 1.76B | |
-7.16% | 1.43B |